Structure

Physi-Chem Properties

Molecular Weight:  436.31
Volume:  476.583
LogP:  3.206
LogD:  3.606
LogS:  -2.961
# Rotatable Bonds:  8
TPSA:  78.41
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.465
Synthetic Accessibility Score:  4.785
Fsp3:  0.538
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.453
MDCK Permeability:  4.131379228056176e-06
Pgp-inhibitor:  0.785
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.947
20% Bioavailability (F20%):  0.922
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.63
Plasma Protein Binding (PPB):  79.85760498046875%
Volume Distribution (VD):  1.258
Pgp-substrate:  31.06209373474121%

ADMET: Metabolism

CYP1A2-inhibitor:  0.013
CYP1A2-substrate:  0.093
CYP2C19-inhibitor:  0.158
CYP2C19-substrate:  0.061
CYP2C9-inhibitor:  0.019
CYP2C9-substrate:  0.252
CYP2D6-inhibitor:  0.98
CYP2D6-substrate:  0.255
CYP3A4-inhibitor:  0.047
CYP3A4-substrate:  0.145

ADMET: Excretion

Clearance (CL):  6.977
Half-life (T1/2):  0.927

ADMET: Toxicity

hERG Blockers:  0.047
Human Hepatotoxicity (H-HT):  0.918
Drug-inuced Liver Injury (DILI):  0.175
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.16
Maximum Recommended Daily Dose:  0.933
Skin Sensitization:  0.903
Carcinogencity:  0.181
Eye Corrosion:  0.003
Eye Irritation:  0.027
Respiratory Toxicity:  0.897

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472833

Natural Product ID:  NPC472833
Common Name*:   VNHUAACDBKEOPD-DQBDHREDSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  VNHUAACDBKEOPD-DQBDHREDSA-N
Standard InCHI:  InChI=1S/C26H38N5O/c1-18(10-12-26(5)20(3)14-22(32)15-21(26)4)8-7-9-19(2)11-13-31-17-30(6)25-23(31)24(27)28-16-29-25/h8,11,14,16-17,21H,7,9-10,12-13,15H2,1-6H3,(H2,27,28,29)/q+1/b18-8+,19-11+/t21-,26-/m0/s1
SMILES:  C/C(=CCC/C(=C/Cn1c[n+](c2c1c(N)ncn2)C)/C)/CC[C@]1(C)[C@@H](C)CC(=O)C=C1C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3586407
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11199 Agelas nakamurai Species Agelasidae Eukaryota n.a. at a depth of 14 m near the island of Ambon (Seram Seilale), Indonesia 1997-AUG PMID[10514317]
NPO11199 Agelas nakamurai Species Agelasidae Eukaryota n.a. n.a. n.a. PMID[14677933]
NPO11199 Agelas nakamurai Species Agelasidae Eukaryota n.a. Okinawan n.a. PMID[26083682]
NPO11199 Agelas nakamurai Species Agelasidae Eukaryota n.a. papua new guinean n.a. PMID[9784179]
NPO11199 Agelas nakamurai Species Agelasidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 > 23000.0 nM PMID[508197]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 50000.0 nM PMID[508197]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472833 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9793 High Similarity NPC472832
0.9793 High Similarity NPC18308
0.9014 High Similarity NPC470266
0.8828 High Similarity NPC476522
0.8828 High Similarity NPC474986
0.8828 High Similarity NPC476013
0.8828 High Similarity NPC476520
0.8811 High Similarity NPC296437
0.8767 High Similarity NPC476521
0.8759 High Similarity NPC476433
0.8759 High Similarity NPC476528
0.8742 High Similarity NPC472834
0.8649 High Similarity NPC476408
0.7987 Intermediate Similarity NPC244700
0.7661 Intermediate Similarity NPC473585
0.7532 Intermediate Similarity NPC226184
0.7532 Intermediate Similarity NPC76544
0.7532 Intermediate Similarity NPC167285
0.75 Intermediate Similarity NPC217656
0.7486 Intermediate Similarity NPC265111
0.7342 Intermediate Similarity NPC89139
0.7283 Intermediate Similarity NPC164845
0.6646 Remote Similarity NPC57279
0.6549 Remote Similarity NPC87981
0.6549 Remote Similarity NPC174114
0.6541 Remote Similarity NPC477118
0.6505 Remote Similarity NPC477120
0.6464 Remote Similarity NPC317054
0.6341 Remote Similarity NPC33996
0.6327 Remote Similarity NPC276373
0.6312 Remote Similarity NPC246193
0.6304 Remote Similarity NPC477119
0.6303 Remote Similarity NPC129756
0.6301 Remote Similarity NPC476564
0.6294 Remote Similarity NPC5802
0.6286 Remote Similarity NPC239737
0.6263 Remote Similarity NPC157821
0.6243 Remote Similarity NPC290959
0.6211 Remote Similarity NPC104011
0.6168 Remote Similarity NPC317821
0.6139 Remote Similarity NPC116555
0.6138 Remote Similarity NPC24589
0.6135 Remote Similarity NPC267811
0.6127 Remote Similarity NPC150853
0.6126 Remote Similarity NPC313514
0.6108 Remote Similarity NPC313897
0.6102 Remote Similarity NPC93365
0.6093 Remote Similarity NPC4837
0.6093 Remote Similarity NPC312187
0.6081 Remote Similarity NPC18335
0.6071 Remote Similarity NPC209525
0.6071 Remote Similarity NPC161659
0.6042 Remote Similarity NPC282458
0.6042 Remote Similarity NPC78941
0.6 Remote Similarity NPC314152
0.6 Remote Similarity NPC229974
0.5988 Remote Similarity NPC189068
0.5962 Remote Similarity NPC68938
0.5954 Remote Similarity NPC309832
0.5954 Remote Similarity NPC219313
0.5938 Remote Similarity NPC476341
0.593 Remote Similarity NPC107374
0.593 Remote Similarity NPC21448
0.593 Remote Similarity NPC156461
0.5896 Remote Similarity NPC164665
0.5886 Remote Similarity NPC136349
0.5876 Remote Similarity NPC133782
0.5876 Remote Similarity NPC527
0.5876 Remote Similarity NPC144474
0.587 Remote Similarity NPC325906
0.5862 Remote Similarity NPC269827
0.5829 Remote Similarity NPC121222
0.582 Remote Similarity NPC189261
0.5819 Remote Similarity NPC161224
0.5815 Remote Similarity NPC324484
0.581 Remote Similarity NPC469975
0.5802 Remote Similarity NPC248007
0.5801 Remote Similarity NPC195140
0.5799 Remote Similarity NPC470323
0.5787 Remote Similarity NPC328479
0.5773 Remote Similarity NPC267078
0.5773 Remote Similarity NPC101676
0.5773 Remote Similarity NPC935
0.5754 Remote Similarity NPC212551
0.5754 Remote Similarity NPC302778
0.5754 Remote Similarity NPC473878
0.5747 Remote Similarity NPC474357
0.5742 Remote Similarity NPC477419
0.5742 Remote Similarity NPC477417
0.573 Remote Similarity NPC85689
0.573 Remote Similarity NPC185991
0.573 Remote Similarity NPC211025
0.5722 Remote Similarity NPC174802
0.5721 Remote Similarity NPC158055
0.5705 Remote Similarity NPC256849
0.5698 Remote Similarity NPC472816
0.5698 Remote Similarity NPC321814
0.5691 Remote Similarity NPC224076
0.5683 Remote Similarity NPC124276
0.5682 Remote Similarity NPC115595
0.5672 Remote Similarity NPC300139
0.5672 Remote Similarity NPC233431
0.5667 Remote Similarity NPC130586
0.5667 Remote Similarity NPC164952
0.566 Remote Similarity NPC189314
0.5659 Remote Similarity NPC226245
0.5658 Remote Similarity NPC476099
0.5644 Remote Similarity NPC109322
0.5635 Remote Similarity NPC217021
0.5635 Remote Similarity NPC470679
0.5633 Remote Similarity NPC477420
0.5633 Remote Similarity NPC477418
0.5632 Remote Similarity NPC8590
0.5628 Remote Similarity NPC250178
0.5619 Remote Similarity NPC191415
0.5617 Remote Similarity NPC139776
0.5611 Remote Similarity NPC207633
0.561 Remote Similarity NPC180493
0.561 Remote Similarity NPC469308

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472833 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7176 Intermediate Similarity NPD8120 Approved
0.7176 Intermediate Similarity NPD8121 Phase 3
0.6845 Remote Similarity NPD7023 Clinical (unspecified phase)
0.6815 Remote Similarity NPD1058 Discontinued
0.6765 Remote Similarity NPD5969 Clinical (unspecified phase)
0.6684 Remote Similarity NPD3431 Approved
0.6684 Remote Similarity NPD3430 Approved
0.6646 Remote Similarity NPD4240 Approved
0.6615 Remote Similarity NPD7323 Phase 2
0.6606 Remote Similarity NPD7158 Phase 1
0.6595 Remote Similarity NPD5684 Clinical (unspecified phase)
0.6595 Remote Similarity NPD5683 Clinical (unspecified phase)
0.6595 Remote Similarity NPD5682 Phase 3
0.6582 Remote Similarity NPD3905 Phase 3
0.6552 Remote Similarity NPD516 Clinical (unspecified phase)
0.6546 Remote Similarity NPD4924 Clinical (unspecified phase)
0.6546 Remote Similarity NPD2879 Approved
0.6546 Remote Similarity NPD2881 Approved
0.6497 Remote Similarity NPD870 Clinical (unspecified phase)
0.6497 Remote Similarity NPD1313 Approved
0.6456 Remote Similarity NPD9633 Phase 3
0.6455 Remote Similarity NPD1658 Discontinued
0.645 Remote Similarity NPD4863 Approved
0.6422 Remote Similarity NPD6470 Phase 3
0.642 Remote Similarity NPD2593 Clinical (unspecified phase)
0.6415 Remote Similarity NPD248 Discontinued
0.6412 Remote Similarity NPD3708 Phase 2
0.641 Remote Similarity NPD6837 Clinical (unspecified phase)
0.6408 Remote Similarity NPD4854 Phase 3
0.6393 Remote Similarity NPD3041 Approved
0.6382 Remote Similarity NPD6521 Phase 3
0.6382 Remote Similarity NPD6520 Phase 3
0.6382 Remote Similarity NPD2443 Approved
0.6382 Remote Similarity NPD2442 Approved
0.6373 Remote Similarity NPD2880 Discontinued
0.6369 Remote Similarity NPD9408 Phase 3
0.6364 Remote Similarity NPD3696 Approved
0.6364 Remote Similarity NPD3695 Approved
0.6353 Remote Similarity NPD4709 Approved
0.635 Remote Similarity NPD2408 Discontinued
0.6347 Remote Similarity NPD3706 Clinical (unspecified phase)
0.6313 Remote Similarity NPD6229 Phase 2
0.6313 Remote Similarity NPD2965 Clinical (unspecified phase)
0.6313 Remote Similarity NPD1333 Phase 3
0.6294 Remote Similarity NPD4183 Phase 3
0.6294 Remote Similarity NPD4182 Phase 3
0.6293 Remote Similarity NPD5643 Phase 2
0.6263 Remote Similarity NPD5016 Approved
0.6256 Remote Similarity NPD1982 Phase 1
0.625 Remote Similarity NPD3839 Phase 2
0.625 Remote Similarity NPD3840 Phase 2
0.6243 Remote Similarity NPD3378 Clinical (unspecified phase)
0.6237 Remote Similarity NPD3362 Clinical (unspecified phase)
0.6236 Remote Similarity NPD6074 Clinical (unspecified phase)
0.6231 Remote Similarity NPD4446 Approved
0.6226 Remote Similarity NPD1775 Approved
0.6226 Remote Similarity NPD1085 Approved
0.6223 Remote Similarity NPD2456 Phase 2
0.6223 Remote Similarity NPD2457 Phase 2
0.6218 Remote Similarity NPD3485 Clinical (unspecified phase)
0.6211 Remote Similarity NPD6418 Phase 1
0.6202 Remote Similarity NPD5827 Discontinued
0.6201 Remote Similarity NPD1015 Phase 2
0.6201 Remote Similarity NPD1016 Phase 2
0.62 Remote Similarity NPD2008 Discontinued
0.6188 Remote Similarity NPD1215 Discontinued
0.6188 Remote Similarity NPD2647 Phase 3
0.6176 Remote Similarity NPD2411 Approved
0.6175 Remote Similarity NPD1567 Clinical (unspecified phase)
0.6175 Remote Similarity NPD3347 Clinical (unspecified phase)
0.6169 Remote Similarity NPD1506 Discontinued
0.6158 Remote Similarity NPD2591 Phase 2
0.615 Remote Similarity NPD5962 Phase 2
0.615 Remote Similarity NPD5508 Phase 1
0.615 Remote Similarity NPD7103 Approved
0.6133 Remote Similarity NPD5269 Clinical (unspecified phase)
0.6126 Remote Similarity NPD7138 Phase 2
0.6124 Remote Similarity NPD5321 Phase 3
0.6118 Remote Similarity NPD171 Discontinued
0.6115 Remote Similarity NPD2221 Clinical (unspecified phase)
0.6114 Remote Similarity NPD3107 Discontinued
0.6114 Remote Similarity NPD6849 Phase 2
0.6114 Remote Similarity NPD6850 Phase 2
0.6108 Remote Similarity NPD3860 Discontinued
0.6108 Remote Similarity NPD7297 Phase 2
0.6102 Remote Similarity NPD546 Clinical (unspecified phase)
0.6096 Remote Similarity NPD3432 Approved
0.6096 Remote Similarity NPD2930 Clinical (unspecified phase)
0.6095 Remote Similarity NPD2179 Discontinued
0.609 Remote Similarity NPD580 Discontinued
0.6082 Remote Similarity NPD6619 Phase 3
0.6081 Remote Similarity NPD8836 Approved
0.6073 Remote Similarity NPD4940 Approved
0.6071 Remote Similarity NPD193 Suspended
0.6071 Remote Similarity NPD4765 Approved
0.6071 Remote Similarity NPD4764 Approved
0.6068 Remote Similarity NPD2363 Discontinued
0.605 Remote Similarity NPD2807 Discontinued
0.6048 Remote Similarity NPD6579 Phase 2
0.6043 Remote Similarity NPD4155 Approved
0.6041 Remote Similarity NPD1952 Discontinued
0.604 Remote Similarity NPD2876 Phase 3
0.604 Remote Similarity NPD2877 Clinical (unspecified phase)
0.604 Remote Similarity NPD6271 Approved
0.6033 Remote Similarity NPD2875 Clinical (unspecified phase)
0.6032 Remote Similarity NPD2523 Phase 2
0.6032 Remote Similarity NPD2526 Phase 2
0.6031 Remote Similarity NPD7434 Approved
0.602 Remote Similarity NPD5464 Approved
0.6019 Remote Similarity NPD7656 Approved
0.6019 Remote Similarity NPD7657 Approved
0.6011 Remote Similarity NPD2646 Discontinued
0.6011 Remote Similarity NPD3341 Clinical (unspecified phase)
0.601 Remote Similarity NPD2453 Phase 2
0.601 Remote Similarity NPD2450 Phase 2
0.601 Remote Similarity NPD2451 Phase 2
0.601 Remote Similarity NPD2452 Phase 2
0.6 Remote Similarity NPD185 Approved
0.6 Remote Similarity NPD5072 Discontinued
0.6 Remote Similarity NPD7722 Suspended
0.5991 Remote Similarity NPD7173 Approved
0.5991 Remote Similarity NPD7172 Approved
0.599 Remote Similarity NPD4902 Discontinued
0.5989 Remote Similarity NPD2524 Discontinued
0.5988 Remote Similarity NPD1730 Discontinued
0.598 Remote Similarity NPD4612 Discontinued
0.598 Remote Similarity NPD2824 Phase 2
0.5979 Remote Similarity NPD4716 Approved
0.5978 Remote Similarity NPD2333 Discontinued
0.5972 Remote Similarity NPD6210 Phase 3
0.5969 Remote Similarity NPD460 Discontinued
0.5968 Remote Similarity NPD1037 Clinical (unspecified phase)
0.5967 Remote Similarity NPD3083 Approved
0.5962 Remote Similarity NPD4395 Phase 1
0.596 Remote Similarity NPD5446 Phase 2
0.5956 Remote Similarity NPD2135 Approved
0.5956 Remote Similarity NPD7988 Suspended
0.5956 Remote Similarity NPD2136 Approved
0.5956 Remote Similarity NPD2134 Approved
0.5952 Remote Similarity NPD4541 Clinical (unspecified phase)
0.5952 Remote Similarity NPD799 Phase 1
0.5951 Remote Similarity NPD2295 Clinical (unspecified phase)
0.5951 Remote Similarity NPD1600 Suspended
0.595 Remote Similarity NPD6816 Phase 3
0.5949 Remote Similarity NPD3419 Clinical (unspecified phase)
0.5947 Remote Similarity NPD4744 Clinical (unspecified phase)
0.5942 Remote Similarity NPD7164 Discontinued
0.5941 Remote Similarity NPD2364 Suspended
0.5936 Remote Similarity NPD5666 Phase 2
0.5933 Remote Similarity NPD2412 Clinical (unspecified phase)
0.593 Remote Similarity NPD249 Approved
0.593 Remote Similarity NPD6469 Phase 3
0.593 Remote Similarity NPD166 Approved
0.593 Remote Similarity NPD6468 Clinical (unspecified phase)
0.593 Remote Similarity NPD250 Approved
0.5924 Remote Similarity NPD578 Discontinued
0.5924 Remote Similarity NPD6794 Approved
0.5918 Remote Similarity NPD5973 Phase 2
0.5918 Remote Similarity NPD4615 Phase 2
0.5918 Remote Similarity NPD5974 Approved
0.5913 Remote Similarity NPD5679 Clinical (unspecified phase)
0.5907 Remote Similarity NPD6721 Phase 1
0.59 Remote Similarity NPD5854 Approved
0.5893 Remote Similarity NPD2602 Clinical (unspecified phase)
0.5891 Remote Similarity NPD6129 Phase 2
0.5889 Remote Similarity NPD2927 Phase 3
0.5886 Remote Similarity NPD548 Clinical (unspecified phase)
0.5882 Remote Similarity NPD5324 Clinical (unspecified phase)
0.588 Remote Similarity NPD7694 Discontinued
0.5876 Remote Similarity NPD2009 Clinical (unspecified phase)
0.5875 Remote Similarity NPD4262 Discontinued
0.5874 Remote Similarity NPD2819 Clinical (unspecified phase)
0.5873 Remote Similarity NPD7111 Discontinued
0.587 Remote Similarity NPD1777 Approved
0.587 Remote Similarity NPD1776 Approved
0.5868 Remote Similarity NPD4763 Clinical (unspecified phase)
0.5865 Remote Similarity NPD4352 Phase 1
0.5865 Remote Similarity NPD2902 Phase 2
0.5865 Remote Similarity NPD2903 Clinical (unspecified phase)
0.5864 Remote Similarity NPD7502 Clinical (unspecified phase)
0.5864 Remote Similarity NPD4649 Clinical (unspecified phase)
0.5862 Remote Similarity NPD4714 Approved
0.5862 Remote Similarity NPD4713 Clinical (unspecified phase)
0.5862 Remote Similarity NPD195 Approved
0.5862 Remote Similarity NPD186 Discovery
0.5862 Remote Similarity NPD34 Approved
0.5862 Remote Similarity NPD7531 Clinical (unspecified phase)
0.5862 Remote Similarity NPD4715 Clinical (unspecified phase)
0.5854 Remote Similarity NPD7445 Phase 1
0.5854 Remote Similarity NPD6328 Clinical (unspecified phase)
0.5853 Remote Similarity NPD1571 Phase 2
0.5853 Remote Similarity NPD7887 Approved
0.5853 Remote Similarity NPD7888 Approved
0.5851 Remote Similarity NPD7006 Approved
0.5848 Remote Similarity NPD2253 Discontinued
0.5846 Remote Similarity NPD7504 Discontinued
0.5845 Remote Similarity NPD6192 Phase 3
0.5842 Remote Similarity NPD5730 Phase 2
0.5842 Remote Similarity NPD40 Phase 2
0.5842 Remote Similarity NPD4142 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data